Merck COVID Pill (Molnupiravir): A New Treatment Option? (Coronavirus Update 130)

Roger Seheult, MD of MedCram on how the molnupiravir pill works as a possible treatment for COVID 19. Safety and efficacy data are reviewed from the study that Merck conducted, and the mechanism of action is illustrated.

Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com
He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.

(This video was recorded on October 20, 2021)

TOPICS IN THIS VIDEO INCLUDE:

00:00 Mechanisms of Molnupiravir, an oral antiviral medication for COVID-19
00:39 Review: How SARS-COV-2 virus infects the cell and replicates
03:25 How Molnupiravir outcompetes other nucleotides to impact SARS-CoV-2 replication
05:06 Data from randomized, placebo-controlled trial that measured Molnupiravir efficacy in COVID-19 patients with symptoms for less than 5 days and not hospitalized
08:59 Data on Molnupiravir vs. Monoclonal Antibodies
10:55 Speculations on long-term safety data of Molnupiravir

LINKS / REFERENCES:

Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death (Merck) | https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/

Early safety concerns accompanied Merck’s molnupiravir, the first potential oral COVID-19 therapy (Drug Discovery & Development) | https://www.drugdiscoverytrends.com/early-safety-concerns-accompanied-mercks-molnupiravir-the-first-potential-oral-covid-19-therapy/

Molnupiravir vs. COVID-19: Will the drug live up to the hype? (Medical News Today) | https://www.medicalnewstoday.com/articles/molnupiravir-vs-covid-19-will-the-drug-live-up-to-the-hype

All coronavirus updates are at MedCram.com (including more discussion on the Merck COVID Pill, COVID delta variant, and more).
SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL:

https://www.youtube.com/user/MEDCRAMvideos?sub_confirmation=1
Get notified of new videos by hitting the bell icon

MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS:

MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested.
MEDIA CONTACT:

Media Contact: customers@medcram.com
Media contact info: https://www.medcram.com/pages/media-contact

Video Produced by Kyle Allred
FOLLOW US ON SOCIAL MEDIA:

https://www.facebook.com/MedCram
https://twitter.com/MedCramVideos
https://www.instagram.com/medcram
DISCLAIMER:

MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

#COVID19 #SARSCoV2 #Coronavirus

Видео Merck COVID Pill (Molnupiravir): A New Treatment Option? (Coronavirus Update 130) канала MedCram - Medical Lectures Explained CLEARLY